Twin Tree Management, LP Summit Therapeutics Inc. Transaction History
Twin Tree Management, LP
- $54.5 Billion
- Q4 2024
A detailed history of Twin Tree Management, LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 232,900 shares of SMMT stock, worth $5.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
232,900
Previous 38,600
503.37%
Holding current value
$5.15 Million
Previous $845,000
391.95%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
232Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$540 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$258 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$175 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$145 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$124 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.45B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...